What is Benzamycin
ErythromycinThe Generic name of this drug
Treatment SummaryErythromycin is an antibiotic used to treat bacterial infections. It was first discovered in 1952 and belongs to a family of antibiotics called macrolides. Erythromycin is effective against both gram-positive and gram-negative bacteria and can be administered in different forms such as intravenous, topical, and eye drops.
Erythrocin Stearateis the brand name
Benzamycin Overview & Background
Brand Name
Generic Name
First FDA Approval
How many FDA approvals?
Erythrocin Stearate
Erythromycin
1964
261
Approved as Treatment by the FDA
Erythromycin, also known as Erythrocin Stearate, is approved by the FDA for 52 uses which include prophylaxis of Postoperative Infections and Syphilis .prophylaxis of Postoperative Infections
Syphilis
Conjunctivitis
inflammatory papular lesions
Used to treat inflammatory papular lesions in combination with Avobenzone
Pneumococcal Infections
Lower Respiratory Tract Infection (LRTI)
pustular lesions
Used to treat pustular lesions in combination with Avobenzone
Listeriosis
Acute Otitis Media caused by Haemophilus Influenzae
Used to treat Acute Otitis Media caused by Haemophilus Influenzae in combination with Sulfisoxazole
Urinary Tract Infection (UTI)
treponema pallidum infection
Listeria monocytogenes infection
Urethritis
Staphylococcal Skin Infections
Haemophilus Influenzae Infections
Used to treat Haemophilus Influenzae Infections in combination with null
Ureaplasma urealyticum
Urethritis
Intestinal amebiasis caused by entamoeba histolytica
Sulfonamides
Upper Respiratory Tract Infection
Communicable Diseases
patients with intolerance or contraindications to tetracycline use
uncomplicated endocervical infection
Pertussis
Communicable Diseases
Staphylococcus (S.) Aureus Infection
Corynebacterium Infections
diphtheria antitoxin
predominant skin comedones, papules and pustules
Used to treat predominant skin comedones, papules and pustules in combination with Tretinoin
Communicable Diseases
Legionella pneumophila
urogenital infections during pregnancy
Diphtheria
penicillins
Rheumatic Fever
Primary Syphilis
Bacterial Infections
penicillins
Erythrasma
Mycoplasma pneumoniae infection
Corynebacterium minutissimum infection
Respiratory Tract Infections
Rheumatic Fever
Streptococcus pyogenes
Chlamydia Trachomatis
Postoperative Infections
Whooping Cough
Communicable Diseases
pneumonia of infancy
Acne Vulgaris
Used to treat Acne Vulgaris in combination with Tretinoin
uncomplicated urethral infection
First episode of rheumatic fever
Effectiveness
How Benzamycin Affects PatientsErythromycin is an antibiotic that works by stopping the growth of bacteria. It has been shown to be effective against many types of bacteria, but it is important to do a test to check if the bacteria is resistant before taking it. Taking erythromycin with sulfonamides has been shown to be effective against some strains of Haemophilus influenzae that are resistant to erythromycin alone. However, some Staphylococci may become resistant to erythromycin and/or sulfonamides during treatment. Taking erythromycin may also cause pseudomembr
How Benzamycin works in the bodyErythromycin is an antibiotic that works by preventing bacteria from making proteins. It binds to the ribosome, which processes the proteins, and stops the bacteria from producing more. This keeps the bacteria from multiplying and causes them to die, treating bacterial infections. Erythromycin works on many types of bacteria, making it a broad-spectrum antibiotic.
When to interrupt dosage
The measure of Benzamycin is dependent upon the determined sickness, including Chlamydia Trachomatis, penicillins and Syphilis. The dosage also varies as per the form of administration (e.g. Granule, for suspension or Tablet, film coated - Oral) specified in the table underneath.Condition
Dosage
Administration
Communicable Diseases
, 5.0 mg/mL, 50.0 mg/mL, 0.005 mg/mg, 15.0 mg/mL, 20.0 mg/mL, 250.0 mg, 200.0 mg/mL, 500.0 mg, 100.0 mg/mL, 250.0 mg/mL, 200.0 mg, 25.0 mg/mL, 125.0 mg/mL, 40.0 mg/mL, 1000.0 mg, 400.0 mg/mL, 20.0 mg, 0.12 mg/mg, 600.0 mg, 0.03 mg/mg, 0.0012 mg/mg, 333.0 mg, 3.0 %, 400.0 mg, 0.0005 mg/mg, 0.008 mL/mL, 0.02 mg/mg, 0.5 %, 4.0 %, 2.0 %, 3.1 mg/mg
Granule, for suspension, Tablet, film coated - Oral, , Tablet, Tablet, delayed release - Oral, Injection, powder, lyophilized, for solution, Gel - Topical, Capsule, Oral, Capsule, coated pellets - Oral, Solution - Topical, Suspension, Intravenous, Capsule, Delayed Release - Oral, Suspension - Oral, Powder, for solution - Intravenous, Ointment, Gel, Injection, powder, for solution, Topical, Powder, for solution - Oral, Tablet, film coated, Tablet - Oral, Tablet, coated - Oral, Kit, Powder, for suspension, Granule, for suspension - Oral, Injection, powder, lyophilized, for solution - Intravenous, Gel; Kit - Topical, For suspension - Oral, Wafer - Oral, Capsule, delayed release pellets - Oral, Kit - Topical, Swab, Capsule, delayed release, Ointment - Ophthalmic, Solution, Powder, for suspension - Oral, Swab - Topical, Injection, powder, for solution - Intravenous, Gel; Kit, Powder, Capsule - Oral, Liquid, Capsule, delayed release - Oral, Tablet, delayed release, Liquid - Oral, Tablet, coated, Powder - Oral, Wafer, Ophthalmic, Capsule, delayed release pellets, Lotion; Swab, Powder, for solution, Lotion - Topical, Capsule, coated pellets, Lotion; Swab - Topical, Ointment - Topical, For suspension, Lotion, Capsule, Delayed Release
Urethritis
, 5.0 mg/mL, 50.0 mg/mL, 0.005 mg/mg, 15.0 mg/mL, 20.0 mg/mL, 250.0 mg, 200.0 mg/mL, 500.0 mg, 100.0 mg/mL, 250.0 mg/mL, 200.0 mg, 25.0 mg/mL, 125.0 mg/mL, 40.0 mg/mL, 1000.0 mg, 400.0 mg/mL, 20.0 mg, 0.12 mg/mg, 600.0 mg, 0.03 mg/mg, 0.0012 mg/mg, 333.0 mg, 3.0 %, 400.0 mg, 0.0005 mg/mg, 0.008 mL/mL, 0.02 mg/mg, 0.5 %, 4.0 %, 2.0 %, 3.1 mg/mg
Granule, for suspension, Tablet, film coated - Oral, , Tablet, Tablet, delayed release - Oral, Injection, powder, lyophilized, for solution, Gel - Topical, Capsule, Oral, Capsule, coated pellets - Oral, Solution - Topical, Suspension, Intravenous, Capsule, Delayed Release - Oral, Suspension - Oral, Powder, for solution - Intravenous, Ointment, Gel, Injection, powder, for solution, Topical, Powder, for solution - Oral, Tablet, film coated, Tablet - Oral, Tablet, coated - Oral, Kit, Powder, for suspension, Granule, for suspension - Oral, Injection, powder, lyophilized, for solution - Intravenous, Gel; Kit - Topical, For suspension - Oral, Wafer - Oral, Capsule, delayed release pellets - Oral, Kit - Topical, Swab, Capsule, delayed release, Ointment - Ophthalmic, Solution, Powder, for suspension - Oral, Swab - Topical, Injection, powder, for solution - Intravenous, Gel; Kit, Powder, Capsule - Oral, Liquid, Capsule, delayed release - Oral, Tablet, delayed release, Liquid - Oral, Tablet, coated, Powder - Oral, Wafer, Ophthalmic, Capsule, delayed release pellets, Lotion; Swab, Powder, for solution, Lotion - Topical, Capsule, coated pellets, Lotion; Swab - Topical, Ointment - Topical, For suspension, Lotion, Capsule, Delayed Release
prophylaxis of Postoperative Infections
, 5.0 mg/mL, 50.0 mg/mL, 0.005 mg/mg, 15.0 mg/mL, 20.0 mg/mL, 250.0 mg, 200.0 mg/mL, 500.0 mg, 100.0 mg/mL, 250.0 mg/mL, 200.0 mg, 25.0 mg/mL, 125.0 mg/mL, 40.0 mg/mL, 1000.0 mg, 400.0 mg/mL, 20.0 mg, 0.12 mg/mg, 600.0 mg, 0.03 mg/mg, 0.0012 mg/mg, 333.0 mg, 3.0 %, 400.0 mg, 0.0005 mg/mg, 0.008 mL/mL, 0.02 mg/mg, 0.5 %, 4.0 %, 2.0 %, 3.1 mg/mg
Granule, for suspension, Tablet, film coated - Oral, , Tablet, Tablet, delayed release - Oral, Injection, powder, lyophilized, for solution, Gel - Topical, Capsule, Oral, Capsule, coated pellets - Oral, Solution - Topical, Suspension, Intravenous, Capsule, Delayed Release - Oral, Suspension - Oral, Powder, for solution - Intravenous, Ointment, Gel, Injection, powder, for solution, Topical, Powder, for solution - Oral, Tablet, film coated, Tablet - Oral, Tablet, coated - Oral, Kit, Powder, for suspension, Granule, for suspension - Oral, Injection, powder, lyophilized, for solution - Intravenous, Gel; Kit - Topical, For suspension - Oral, Wafer - Oral, Capsule, delayed release pellets - Oral, Kit - Topical, Swab, Capsule, delayed release, Ointment - Ophthalmic, Solution, Powder, for suspension - Oral, Swab - Topical, Injection, powder, for solution - Intravenous, Gel; Kit, Powder, Capsule - Oral, Liquid, Capsule, delayed release - Oral, Tablet, delayed release, Liquid - Oral, Tablet, coated, Powder - Oral, Wafer, Ophthalmic, Capsule, delayed release pellets, Lotion; Swab, Powder, for solution, Lotion - Topical, Capsule, coated pellets, Lotion; Swab - Topical, Ointment - Topical, For suspension, Lotion, Capsule, Delayed Release
Haemophilus Influenzae Infections
, 5.0 mg/mL, 50.0 mg/mL, 0.005 mg/mg, 15.0 mg/mL, 20.0 mg/mL, 250.0 mg, 200.0 mg/mL, 500.0 mg, 100.0 mg/mL, 250.0 mg/mL, 200.0 mg, 25.0 mg/mL, 125.0 mg/mL, 40.0 mg/mL, 1000.0 mg, 400.0 mg/mL, 20.0 mg, 0.12 mg/mg, 600.0 mg, 0.03 mg/mg, 0.0012 mg/mg, 333.0 mg, 3.0 %, 400.0 mg, 0.0005 mg/mg, 0.008 mL/mL, 0.02 mg/mg, 0.5 %, 4.0 %, 2.0 %, 3.1 mg/mg
Granule, for suspension, Tablet, film coated - Oral, , Tablet, Tablet, delayed release - Oral, Injection, powder, lyophilized, for solution, Gel - Topical, Capsule, Oral, Capsule, coated pellets - Oral, Solution - Topical, Suspension, Intravenous, Capsule, Delayed Release - Oral, Suspension - Oral, Powder, for solution - Intravenous, Ointment, Gel, Injection, powder, for solution, Topical, Powder, for solution - Oral, Tablet, film coated, Tablet - Oral, Tablet, coated - Oral, Kit, Powder, for suspension, Granule, for suspension - Oral, Injection, powder, lyophilized, for solution - Intravenous, Gel; Kit - Topical, For suspension - Oral, Wafer - Oral, Capsule, delayed release pellets - Oral, Kit - Topical, Swab, Capsule, delayed release, Ointment - Ophthalmic, Solution, Powder, for suspension - Oral, Swab - Topical, Injection, powder, for solution - Intravenous, Gel; Kit, Powder, Capsule - Oral, Liquid, Capsule, delayed release - Oral, Tablet, delayed release, Liquid - Oral, Tablet, coated, Powder - Oral, Wafer, Ophthalmic, Capsule, delayed release pellets, Lotion; Swab, Powder, for solution, Lotion - Topical, Capsule, coated pellets, Lotion; Swab - Topical, Ointment - Topical, For suspension, Lotion, Capsule, Delayed Release
Rheumatic Fever
, 5.0 mg/mL, 50.0 mg/mL, 0.005 mg/mg, 15.0 mg/mL, 20.0 mg/mL, 250.0 mg, 200.0 mg/mL, 500.0 mg, 100.0 mg/mL, 250.0 mg/mL, 200.0 mg, 25.0 mg/mL, 125.0 mg/mL, 40.0 mg/mL, 1000.0 mg, 400.0 mg/mL, 20.0 mg, 0.12 mg/mg, 600.0 mg, 0.03 mg/mg, 0.0012 mg/mg, 333.0 mg, 3.0 %, 400.0 mg, 0.0005 mg/mg, 0.008 mL/mL, 0.02 mg/mg, 0.5 %, 4.0 %, 2.0 %, 3.1 mg/mg
Granule, for suspension, Tablet, film coated - Oral, , Tablet, Tablet, delayed release - Oral, Injection, powder, lyophilized, for solution, Gel - Topical, Capsule, Oral, Capsule, coated pellets - Oral, Solution - Topical, Suspension, Intravenous, Capsule, Delayed Release - Oral, Suspension - Oral, Powder, for solution - Intravenous, Ointment, Gel, Injection, powder, for solution, Topical, Powder, for solution - Oral, Tablet, film coated, Tablet - Oral, Tablet, coated - Oral, Kit, Powder, for suspension, Granule, for suspension - Oral, Injection, powder, lyophilized, for solution - Intravenous, Gel; Kit - Topical, For suspension - Oral, Wafer - Oral, Capsule, delayed release pellets - Oral, Kit - Topical, Swab, Capsule, delayed release, Ointment - Ophthalmic, Solution, Powder, for suspension - Oral, Swab - Topical, Injection, powder, for solution - Intravenous, Gel; Kit, Powder, Capsule - Oral, Liquid, Capsule, delayed release - Oral, Tablet, delayed release, Liquid - Oral, Tablet, coated, Powder - Oral, Wafer, Ophthalmic, Capsule, delayed release pellets, Lotion; Swab, Powder, for solution, Lotion - Topical, Capsule, coated pellets, Lotion; Swab - Topical, Ointment - Topical, For suspension, Lotion, Capsule, Delayed Release
Ophthalmia neonatorum (gonococcal)
, 5.0 mg/mL, 50.0 mg/mL, 0.005 mg/mg, 15.0 mg/mL, 20.0 mg/mL, 250.0 mg, 200.0 mg/mL, 500.0 mg, 100.0 mg/mL, 250.0 mg/mL, 200.0 mg, 25.0 mg/mL, 125.0 mg/mL, 40.0 mg/mL, 1000.0 mg, 400.0 mg/mL, 20.0 mg, 0.12 mg/mg, 600.0 mg, 0.03 mg/mg, 0.0012 mg/mg, 333.0 mg, 3.0 %, 400.0 mg, 0.0005 mg/mg, 0.008 mL/mL, 0.02 mg/mg, 0.5 %, 4.0 %, 2.0 %, 3.1 mg/mg
Granule, for suspension, Tablet, film coated - Oral, , Tablet, Tablet, delayed release - Oral, Injection, powder, lyophilized, for solution, Gel - Topical, Capsule, Oral, Capsule, coated pellets - Oral, Solution - Topical, Suspension, Intravenous, Capsule, Delayed Release - Oral, Suspension - Oral, Powder, for solution - Intravenous, Ointment, Gel, Injection, powder, for solution, Topical, Powder, for solution - Oral, Tablet, film coated, Tablet - Oral, Tablet, coated - Oral, Kit, Powder, for suspension, Granule, for suspension - Oral, Injection, powder, lyophilized, for solution - Intravenous, Gel; Kit - Topical, For suspension - Oral, Wafer - Oral, Capsule, delayed release pellets - Oral, Kit - Topical, Swab, Capsule, delayed release, Ointment - Ophthalmic, Solution, Powder, for suspension - Oral, Swab - Topical, Injection, powder, for solution - Intravenous, Gel; Kit, Powder, Capsule - Oral, Liquid, Capsule, delayed release - Oral, Tablet, delayed release, Liquid - Oral, Tablet, coated, Powder - Oral, Wafer, Ophthalmic, Capsule, delayed release pellets, Lotion; Swab, Powder, for solution, Lotion - Topical, Capsule, coated pellets, Lotion; Swab - Topical, Ointment - Topical, For suspension, Lotion, Capsule, Delayed Release
Urethritis
, 5.0 mg/mL, 50.0 mg/mL, 0.005 mg/mg, 15.0 mg/mL, 20.0 mg/mL, 250.0 mg, 200.0 mg/mL, 500.0 mg, 100.0 mg/mL, 250.0 mg/mL, 200.0 mg, 25.0 mg/mL, 125.0 mg/mL, 40.0 mg/mL, 1000.0 mg, 400.0 mg/mL, 20.0 mg, 0.12 mg/mg, 600.0 mg, 0.03 mg/mg, 0.0012 mg/mg, 333.0 mg, 3.0 %, 400.0 mg, 0.0005 mg/mg, 0.008 mL/mL, 0.02 mg/mg, 0.5 %, 4.0 %, 2.0 %, 3.1 mg/mg
Granule, for suspension, Tablet, film coated - Oral, , Tablet, Tablet, delayed release - Oral, Injection, powder, lyophilized, for solution, Gel - Topical, Capsule, Oral, Capsule, coated pellets - Oral, Solution - Topical, Suspension, Intravenous, Capsule, Delayed Release - Oral, Suspension - Oral, Powder, for solution - Intravenous, Ointment, Gel, Injection, powder, for solution, Topical, Powder, for solution - Oral, Tablet, film coated, Tablet - Oral, Tablet, coated - Oral, Kit, Powder, for suspension, Granule, for suspension - Oral, Injection, powder, lyophilized, for solution - Intravenous, Gel; Kit - Topical, For suspension - Oral, Wafer - Oral, Capsule, delayed release pellets - Oral, Kit - Topical, Swab, Capsule, delayed release, Ointment - Ophthalmic, Solution, Powder, for suspension - Oral, Swab - Topical, Injection, powder, for solution - Intravenous, Gel; Kit, Powder, Capsule - Oral, Liquid, Capsule, delayed release - Oral, Tablet, delayed release, Liquid - Oral, Tablet, coated, Powder - Oral, Wafer, Ophthalmic, Capsule, delayed release pellets, Lotion; Swab, Powder, for solution, Lotion - Topical, Capsule, coated pellets, Lotion; Swab - Topical, Ointment - Topical, For suspension, Lotion, Capsule, Delayed Release
pustular lesions
, 5.0 mg/mL, 50.0 mg/mL, 0.005 mg/mg, 15.0 mg/mL, 20.0 mg/mL, 250.0 mg, 200.0 mg/mL, 500.0 mg, 100.0 mg/mL, 250.0 mg/mL, 200.0 mg, 25.0 mg/mL, 125.0 mg/mL, 40.0 mg/mL, 1000.0 mg, 400.0 mg/mL, 20.0 mg, 0.12 mg/mg, 600.0 mg, 0.03 mg/mg, 0.0012 mg/mg, 333.0 mg, 3.0 %, 400.0 mg, 0.0005 mg/mg, 0.008 mL/mL, 0.02 mg/mg, 0.5 %, 4.0 %, 2.0 %, 3.1 mg/mg
Granule, for suspension, Tablet, film coated - Oral, , Tablet, Tablet, delayed release - Oral, Injection, powder, lyophilized, for solution, Gel - Topical, Capsule, Oral, Capsule, coated pellets - Oral, Solution - Topical, Suspension, Intravenous, Capsule, Delayed Release - Oral, Suspension - Oral, Powder, for solution - Intravenous, Ointment, Gel, Injection, powder, for solution, Topical, Powder, for solution - Oral, Tablet, film coated, Tablet - Oral, Tablet, coated - Oral, Kit, Powder, for suspension, Granule, for suspension - Oral, Injection, powder, lyophilized, for solution - Intravenous, Gel; Kit - Topical, For suspension - Oral, Wafer - Oral, Capsule, delayed release pellets - Oral, Kit - Topical, Swab, Capsule, delayed release, Ointment - Ophthalmic, Solution, Powder, for suspension - Oral, Swab - Topical, Injection, powder, for solution - Intravenous, Gel; Kit, Powder, Capsule - Oral, Liquid, Capsule, delayed release - Oral, Tablet, delayed release, Liquid - Oral, Tablet, coated, Powder - Oral, Wafer, Ophthalmic, Capsule, delayed release pellets, Lotion; Swab, Powder, for solution, Lotion - Topical, Capsule, coated pellets, Lotion; Swab - Topical, Ointment - Topical, For suspension, Lotion, Capsule, Delayed Release
uncomplicated endocervical infection
, 5.0 mg/mL, 50.0 mg/mL, 0.005 mg/mg, 15.0 mg/mL, 20.0 mg/mL, 250.0 mg, 200.0 mg/mL, 500.0 mg, 100.0 mg/mL, 250.0 mg/mL, 200.0 mg, 25.0 mg/mL, 125.0 mg/mL, 40.0 mg/mL, 1000.0 mg, 400.0 mg/mL, 20.0 mg, 0.12 mg/mg, 600.0 mg, 0.03 mg/mg, 0.0012 mg/mg, 333.0 mg, 3.0 %, 400.0 mg, 0.0005 mg/mg, 0.008 mL/mL, 0.02 mg/mg, 0.5 %, 4.0 %, 2.0 %, 3.1 mg/mg
Granule, for suspension, Tablet, film coated - Oral, , Tablet, Tablet, delayed release - Oral, Injection, powder, lyophilized, for solution, Gel - Topical, Capsule, Oral, Capsule, coated pellets - Oral, Solution - Topical, Suspension, Intravenous, Capsule, Delayed Release - Oral, Suspension - Oral, Powder, for solution - Intravenous, Ointment, Gel, Injection, powder, for solution, Topical, Powder, for solution - Oral, Tablet, film coated, Tablet - Oral, Tablet, coated - Oral, Kit, Powder, for suspension, Granule, for suspension - Oral, Injection, powder, lyophilized, for solution - Intravenous, Gel; Kit - Topical, For suspension - Oral, Wafer - Oral, Capsule, delayed release pellets - Oral, Kit - Topical, Swab, Capsule, delayed release, Ointment - Ophthalmic, Solution, Powder, for suspension - Oral, Swab - Topical, Injection, powder, for solution - Intravenous, Gel; Kit, Powder, Capsule - Oral, Liquid, Capsule, delayed release - Oral, Tablet, delayed release, Liquid - Oral, Tablet, coated, Powder - Oral, Wafer, Ophthalmic, Capsule, delayed release pellets, Lotion; Swab, Powder, for solution, Lotion - Topical, Capsule, coated pellets, Lotion; Swab - Topical, Ointment - Topical, For suspension, Lotion, Capsule, Delayed Release
uncomplicated urethral infection
, 5.0 mg/mL, 50.0 mg/mL, 0.005 mg/mg, 15.0 mg/mL, 20.0 mg/mL, 250.0 mg, 200.0 mg/mL, 500.0 mg, 100.0 mg/mL, 250.0 mg/mL, 200.0 mg, 25.0 mg/mL, 125.0 mg/mL, 40.0 mg/mL, 1000.0 mg, 400.0 mg/mL, 20.0 mg, 0.12 mg/mg, 600.0 mg, 0.03 mg/mg, 0.0012 mg/mg, 333.0 mg, 3.0 %, 400.0 mg, 0.0005 mg/mg, 0.008 mL/mL, 0.02 mg/mg, 0.5 %, 4.0 %, 2.0 %, 3.1 mg/mg
Granule, for suspension, Tablet, film coated - Oral, , Tablet, Tablet, delayed release - Oral, Injection, powder, lyophilized, for solution, Gel - Topical, Capsule, Oral, Capsule, coated pellets - Oral, Solution - Topical, Suspension, Intravenous, Capsule, Delayed Release - Oral, Suspension - Oral, Powder, for solution - Intravenous, Ointment, Gel, Injection, powder, for solution, Topical, Powder, for solution - Oral, Tablet, film coated, Tablet - Oral, Tablet, coated - Oral, Kit, Powder, for suspension, Granule, for suspension - Oral, Injection, powder, lyophilized, for solution - Intravenous, Gel; Kit - Topical, For suspension - Oral, Wafer - Oral, Capsule, delayed release pellets - Oral, Kit - Topical, Swab, Capsule, delayed release, Ointment - Ophthalmic, Solution, Powder, for suspension - Oral, Swab - Topical, Injection, powder, for solution - Intravenous, Gel; Kit, Powder, Capsule - Oral, Liquid, Capsule, delayed release - Oral, Tablet, delayed release, Liquid - Oral, Tablet, coated, Powder - Oral, Wafer, Ophthalmic, Capsule, delayed release pellets, Lotion; Swab, Powder, for solution, Lotion - Topical, Capsule, coated pellets, Lotion; Swab - Topical, Ointment - Topical, For suspension, Lotion, Capsule, Delayed Release
Acne
, 5.0 mg/mL, 50.0 mg/mL, 0.005 mg/mg, 15.0 mg/mL, 20.0 mg/mL, 250.0 mg, 200.0 mg/mL, 500.0 mg, 100.0 mg/mL, 250.0 mg/mL, 200.0 mg, 25.0 mg/mL, 125.0 mg/mL, 40.0 mg/mL, 1000.0 mg, 400.0 mg/mL, 20.0 mg, 0.12 mg/mg, 600.0 mg, 0.03 mg/mg, 0.0012 mg/mg, 333.0 mg, 3.0 %, 400.0 mg, 0.0005 mg/mg, 0.008 mL/mL, 0.02 mg/mg, 0.5 %, 4.0 %, 2.0 %, 3.1 mg/mg
Granule, for suspension, Tablet, film coated - Oral, , Tablet, Tablet, delayed release - Oral, Injection, powder, lyophilized, for solution, Gel - Topical, Capsule, Oral, Capsule, coated pellets - Oral, Solution - Topical, Suspension, Intravenous, Capsule, Delayed Release - Oral, Suspension - Oral, Powder, for solution - Intravenous, Ointment, Gel, Injection, powder, for solution, Topical, Powder, for solution - Oral, Tablet, film coated, Tablet - Oral, Tablet, coated - Oral, Kit, Powder, for suspension, Granule, for suspension - Oral, Injection, powder, lyophilized, for solution - Intravenous, Gel; Kit - Topical, For suspension - Oral, Wafer - Oral, Capsule, delayed release pellets - Oral, Kit - Topical, Swab, Capsule, delayed release, Ointment - Ophthalmic, Solution, Powder, for suspension - Oral, Swab - Topical, Injection, powder, for solution - Intravenous, Gel; Kit, Powder, Capsule - Oral, Liquid, Capsule, delayed release - Oral, Tablet, delayed release, Liquid - Oral, Tablet, coated, Powder - Oral, Wafer, Ophthalmic, Capsule, delayed release pellets, Lotion; Swab, Powder, for solution, Lotion - Topical, Capsule, coated pellets, Lotion; Swab - Topical, Ointment - Topical, For suspension, Lotion, Capsule, Delayed Release
predominant skin comedones, papules and pustules
, 5.0 mg/mL, 50.0 mg/mL, 0.005 mg/mg, 15.0 mg/mL, 20.0 mg/mL, 250.0 mg, 200.0 mg/mL, 500.0 mg, 100.0 mg/mL, 250.0 mg/mL, 200.0 mg, 25.0 mg/mL, 125.0 mg/mL, 40.0 mg/mL, 1000.0 mg, 400.0 mg/mL, 20.0 mg, 0.12 mg/mg, 600.0 mg, 0.03 mg/mg, 0.0012 mg/mg, 333.0 mg, 3.0 %, 400.0 mg, 0.0005 mg/mg, 0.008 mL/mL, 0.02 mg/mg, 0.5 %, 4.0 %, 2.0 %, 3.1 mg/mg
Granule, for suspension, Tablet, film coated - Oral, , Tablet, Tablet, delayed release - Oral, Injection, powder, lyophilized, for solution, Gel - Topical, Capsule, Oral, Capsule, coated pellets - Oral, Solution - Topical, Suspension, Intravenous, Capsule, Delayed Release - Oral, Suspension - Oral, Powder, for solution - Intravenous, Ointment, Gel, Injection, powder, for solution, Topical, Powder, for solution - Oral, Tablet, film coated, Tablet - Oral, Tablet, coated - Oral, Kit, Powder, for suspension, Granule, for suspension - Oral, Injection, powder, lyophilized, for solution - Intravenous, Gel; Kit - Topical, For suspension - Oral, Wafer - Oral, Capsule, delayed release pellets - Oral, Kit - Topical, Swab, Capsule, delayed release, Ointment - Ophthalmic, Solution, Powder, for suspension - Oral, Swab - Topical, Injection, powder, for solution - Intravenous, Gel; Kit, Powder, Capsule - Oral, Liquid, Capsule, delayed release - Oral, Tablet, delayed release, Liquid - Oral, Tablet, coated, Powder - Oral, Wafer, Ophthalmic, Capsule, delayed release pellets, Lotion; Swab, Powder, for solution, Lotion - Topical, Capsule, coated pellets, Lotion; Swab - Topical, Ointment - Topical, For suspension, Lotion, Capsule, Delayed Release
Corynebacterium minutissimum infection
, 5.0 mg/mL, 50.0 mg/mL, 0.005 mg/mg, 15.0 mg/mL, 20.0 mg/mL, 250.0 mg, 200.0 mg/mL, 500.0 mg, 100.0 mg/mL, 250.0 mg/mL, 200.0 mg, 25.0 mg/mL, 125.0 mg/mL, 40.0 mg/mL, 1000.0 mg, 400.0 mg/mL, 20.0 mg, 0.12 mg/mg, 600.0 mg, 0.03 mg/mg, 0.0012 mg/mg, 333.0 mg, 3.0 %, 400.0 mg, 0.0005 mg/mg, 0.008 mL/mL, 0.02 mg/mg, 0.5 %, 4.0 %, 2.0 %, 3.1 mg/mg
Granule, for suspension, Tablet, film coated - Oral, , Tablet, Tablet, delayed release - Oral, Injection, powder, lyophilized, for solution, Gel - Topical, Capsule, Oral, Capsule, coated pellets - Oral, Solution - Topical, Suspension, Intravenous, Capsule, Delayed Release - Oral, Suspension - Oral, Powder, for solution - Intravenous, Ointment, Gel, Injection, powder, for solution, Topical, Powder, for solution - Oral, Tablet, film coated, Tablet - Oral, Tablet, coated - Oral, Kit, Powder, for suspension, Granule, for suspension - Oral, Injection, powder, lyophilized, for solution - Intravenous, Gel; Kit - Topical, For suspension - Oral, Wafer - Oral, Capsule, delayed release pellets - Oral, Kit - Topical, Swab, Capsule, delayed release, Ointment - Ophthalmic, Solution, Powder, for suspension - Oral, Swab - Topical, Injection, powder, for solution - Intravenous, Gel; Kit, Powder, Capsule - Oral, Liquid, Capsule, delayed release - Oral, Tablet, delayed release, Liquid - Oral, Tablet, coated, Powder - Oral, Wafer, Ophthalmic, Capsule, delayed release pellets, Lotion; Swab, Powder, for solution, Lotion - Topical, Capsule, coated pellets, Lotion; Swab - Topical, Ointment - Topical, For suspension, Lotion, Capsule, Delayed Release
inflammatory papular lesions
, 5.0 mg/mL, 50.0 mg/mL, 0.005 mg/mg, 15.0 mg/mL, 20.0 mg/mL, 250.0 mg, 200.0 mg/mL, 500.0 mg, 100.0 mg/mL, 250.0 mg/mL, 200.0 mg, 25.0 mg/mL, 125.0 mg/mL, 40.0 mg/mL, 1000.0 mg, 400.0 mg/mL, 20.0 mg, 0.12 mg/mg, 600.0 mg, 0.03 mg/mg, 0.0012 mg/mg, 333.0 mg, 3.0 %, 400.0 mg, 0.0005 mg/mg, 0.008 mL/mL, 0.02 mg/mg, 0.5 %, 4.0 %, 2.0 %, 3.1 mg/mg
Granule, for suspension, Tablet, film coated - Oral, , Tablet, Tablet, delayed release - Oral, Injection, powder, lyophilized, for solution, Gel - Topical, Capsule, Oral, Capsule, coated pellets - Oral, Solution - Topical, Suspension, Intravenous, Capsule, Delayed Release - Oral, Suspension - Oral, Powder, for solution - Intravenous, Ointment, Gel, Injection, powder, for solution, Topical, Powder, for solution - Oral, Tablet, film coated, Tablet - Oral, Tablet, coated - Oral, Kit, Powder, for suspension, Granule, for suspension - Oral, Injection, powder, lyophilized, for solution - Intravenous, Gel; Kit - Topical, For suspension - Oral, Wafer - Oral, Capsule, delayed release pellets - Oral, Kit - Topical, Swab, Capsule, delayed release, Ointment - Ophthalmic, Solution, Powder, for suspension - Oral, Swab - Topical, Injection, powder, for solution - Intravenous, Gel; Kit, Powder, Capsule - Oral, Liquid, Capsule, delayed release - Oral, Tablet, delayed release, Liquid - Oral, Tablet, coated, Powder - Oral, Wafer, Ophthalmic, Capsule, delayed release pellets, Lotion; Swab, Powder, for solution, Lotion - Topical, Capsule, coated pellets, Lotion; Swab - Topical, Ointment - Topical, For suspension, Lotion, Capsule, Delayed Release
Chancroid
, 5.0 mg/mL, 50.0 mg/mL, 0.005 mg/mg, 15.0 mg/mL, 20.0 mg/mL, 250.0 mg, 200.0 mg/mL, 500.0 mg, 100.0 mg/mL, 250.0 mg/mL, 200.0 mg, 25.0 mg/mL, 125.0 mg/mL, 40.0 mg/mL, 1000.0 mg, 400.0 mg/mL, 20.0 mg, 0.12 mg/mg, 600.0 mg, 0.03 mg/mg, 0.0012 mg/mg, 333.0 mg, 3.0 %, 400.0 mg, 0.0005 mg/mg, 0.008 mL/mL, 0.02 mg/mg, 0.5 %, 4.0 %, 2.0 %, 3.1 mg/mg
Granule, for suspension, Tablet, film coated - Oral, , Tablet, Tablet, delayed release - Oral, Injection, powder, lyophilized, for solution, Gel - Topical, Capsule, Oral, Capsule, coated pellets - Oral, Solution - Topical, Suspension, Intravenous, Capsule, Delayed Release - Oral, Suspension - Oral, Powder, for solution - Intravenous, Ointment, Gel, Injection, powder, for solution, Topical, Powder, for solution - Oral, Tablet, film coated, Tablet - Oral, Tablet, coated - Oral, Kit, Powder, for suspension, Granule, for suspension - Oral, Injection, powder, lyophilized, for solution - Intravenous, Gel; Kit - Topical, For suspension - Oral, Wafer - Oral, Capsule, delayed release pellets - Oral, Kit - Topical, Swab, Capsule, delayed release, Ointment - Ophthalmic, Solution, Powder, for suspension - Oral, Swab - Topical, Injection, powder, for solution - Intravenous, Gel; Kit, Powder, Capsule - Oral, Liquid, Capsule, delayed release - Oral, Tablet, delayed release, Liquid - Oral, Tablet, coated, Powder - Oral, Wafer, Ophthalmic, Capsule, delayed release pellets, Lotion; Swab, Powder, for solution, Lotion - Topical, Capsule, coated pellets, Lotion; Swab - Topical, Ointment - Topical, For suspension, Lotion, Capsule, Delayed Release
Communicable Diseases
, 5.0 mg/mL, 50.0 mg/mL, 0.005 mg/mg, 15.0 mg/mL, 20.0 mg/mL, 250.0 mg, 200.0 mg/mL, 500.0 mg, 100.0 mg/mL, 250.0 mg/mL, 200.0 mg, 25.0 mg/mL, 125.0 mg/mL, 40.0 mg/mL, 1000.0 mg, 400.0 mg/mL, 20.0 mg, 0.12 mg/mg, 600.0 mg, 0.03 mg/mg, 0.0012 mg/mg, 333.0 mg, 3.0 %, 400.0 mg, 0.0005 mg/mg, 0.008 mL/mL, 0.02 mg/mg, 0.5 %, 4.0 %, 2.0 %, 3.1 mg/mg
Granule, for suspension, Tablet, film coated - Oral, , Tablet, Tablet, delayed release - Oral, Injection, powder, lyophilized, for solution, Gel - Topical, Capsule, Oral, Capsule, coated pellets - Oral, Solution - Topical, Suspension, Intravenous, Capsule, Delayed Release - Oral, Suspension - Oral, Powder, for solution - Intravenous, Ointment, Gel, Injection, powder, for solution, Topical, Powder, for solution - Oral, Tablet, film coated, Tablet - Oral, Tablet, coated - Oral, Kit, Powder, for suspension, Granule, for suspension - Oral, Injection, powder, lyophilized, for solution - Intravenous, Gel; Kit - Topical, For suspension - Oral, Wafer - Oral, Capsule, delayed release pellets - Oral, Kit - Topical, Swab, Capsule, delayed release, Ointment - Ophthalmic, Solution, Powder, for suspension - Oral, Swab - Topical, Injection, powder, for solution - Intravenous, Gel; Kit, Powder, Capsule - Oral, Liquid, Capsule, delayed release - Oral, Tablet, delayed release, Liquid - Oral, Tablet, coated, Powder - Oral, Wafer, Ophthalmic, Capsule, delayed release pellets, Lotion; Swab, Powder, for solution, Lotion - Topical, Capsule, coated pellets, Lotion; Swab - Topical, Ointment - Topical, For suspension, Lotion, Capsule, Delayed Release
Communicable Diseases
, 5.0 mg/mL, 50.0 mg/mL, 0.005 mg/mg, 15.0 mg/mL, 20.0 mg/mL, 250.0 mg, 200.0 mg/mL, 500.0 mg, 100.0 mg/mL, 250.0 mg/mL, 200.0 mg, 25.0 mg/mL, 125.0 mg/mL, 40.0 mg/mL, 1000.0 mg, 400.0 mg/mL, 20.0 mg, 0.12 mg/mg, 600.0 mg, 0.03 mg/mg, 0.0012 mg/mg, 333.0 mg, 3.0 %, 400.0 mg, 0.0005 mg/mg, 0.008 mL/mL, 0.02 mg/mg, 0.5 %, 4.0 %, 2.0 %, 3.1 mg/mg
Granule, for suspension, Tablet, film coated - Oral, , Tablet, Tablet, delayed release - Oral, Injection, powder, lyophilized, for solution, Gel - Topical, Capsule, Oral, Capsule, coated pellets - Oral, Solution - Topical, Suspension, Intravenous, Capsule, Delayed Release - Oral, Suspension - Oral, Powder, for solution - Intravenous, Ointment, Gel, Injection, powder, for solution, Topical, Powder, for solution - Oral, Tablet, film coated, Tablet - Oral, Tablet, coated - Oral, Kit, Powder, for suspension, Granule, for suspension - Oral, Injection, powder, lyophilized, for solution - Intravenous, Gel; Kit - Topical, For suspension - Oral, Wafer - Oral, Capsule, delayed release pellets - Oral, Kit - Topical, Swab, Capsule, delayed release, Ointment - Ophthalmic, Solution, Powder, for suspension - Oral, Swab - Topical, Injection, powder, for solution - Intravenous, Gel; Kit, Powder, Capsule - Oral, Liquid, Capsule, delayed release - Oral, Tablet, delayed release, Liquid - Oral, Tablet, coated, Powder - Oral, Wafer, Ophthalmic, Capsule, delayed release pellets, Lotion; Swab, Powder, for solution, Lotion - Topical, Capsule, coated pellets, Lotion; Swab - Topical, Ointment - Topical, For suspension, Lotion, Capsule, Delayed Release
diphtheria antitoxin
, 5.0 mg/mL, 50.0 mg/mL, 0.005 mg/mg, 15.0 mg/mL, 20.0 mg/mL, 250.0 mg, 200.0 mg/mL, 500.0 mg, 100.0 mg/mL, 250.0 mg/mL, 200.0 mg, 25.0 mg/mL, 125.0 mg/mL, 40.0 mg/mL, 1000.0 mg, 400.0 mg/mL, 20.0 mg, 0.12 mg/mg, 600.0 mg, 0.03 mg/mg, 0.0012 mg/mg, 333.0 mg, 3.0 %, 400.0 mg, 0.0005 mg/mg, 0.008 mL/mL, 0.02 mg/mg, 0.5 %, 4.0 %, 2.0 %, 3.1 mg/mg
Granule, for suspension, Tablet, film coated - Oral, , Tablet, Tablet, delayed release - Oral, Injection, powder, lyophilized, for solution, Gel - Topical, Capsule, Oral, Capsule, coated pellets - Oral, Solution - Topical, Suspension, Intravenous, Capsule, Delayed Release - Oral, Suspension - Oral, Powder, for solution - Intravenous, Ointment, Gel, Injection, powder, for solution, Topical, Powder, for solution - Oral, Tablet, film coated, Tablet - Oral, Tablet, coated - Oral, Kit, Powder, for suspension, Granule, for suspension - Oral, Injection, powder, lyophilized, for solution - Intravenous, Gel; Kit - Topical, For suspension - Oral, Wafer - Oral, Capsule, delayed release pellets - Oral, Kit - Topical, Swab, Capsule, delayed release, Ointment - Ophthalmic, Solution, Powder, for suspension - Oral, Swab - Topical, Injection, powder, for solution - Intravenous, Gel; Kit, Powder, Capsule - Oral, Liquid, Capsule, delayed release - Oral, Tablet, delayed release, Liquid - Oral, Tablet, coated, Powder - Oral, Wafer, Ophthalmic, Capsule, delayed release pellets, Lotion; Swab, Powder, for solution, Lotion - Topical, Capsule, coated pellets, Lotion; Swab - Topical, Ointment - Topical, For suspension, Lotion, Capsule, Delayed Release
Lymphogranuloma Venereum
, 5.0 mg/mL, 50.0 mg/mL, 0.005 mg/mg, 15.0 mg/mL, 20.0 mg/mL, 250.0 mg, 200.0 mg/mL, 500.0 mg, 100.0 mg/mL, 250.0 mg/mL, 200.0 mg, 25.0 mg/mL, 125.0 mg/mL, 40.0 mg/mL, 1000.0 mg, 400.0 mg/mL, 20.0 mg, 0.12 mg/mg, 600.0 mg, 0.03 mg/mg, 0.0012 mg/mg, 333.0 mg, 3.0 %, 400.0 mg, 0.0005 mg/mg, 0.008 mL/mL, 0.02 mg/mg, 0.5 %, 4.0 %, 2.0 %, 3.1 mg/mg
Granule, for suspension, Tablet, film coated - Oral, , Tablet, Tablet, delayed release - Oral, Injection, powder, lyophilized, for solution, Gel - Topical, Capsule, Oral, Capsule, coated pellets - Oral, Solution - Topical, Suspension, Intravenous, Capsule, Delayed Release - Oral, Suspension - Oral, Powder, for solution - Intravenous, Ointment, Gel, Injection, powder, for solution, Topical, Powder, for solution - Oral, Tablet, film coated, Tablet - Oral, Tablet, coated - Oral, Kit, Powder, for suspension, Granule, for suspension - Oral, Injection, powder, lyophilized, for solution - Intravenous, Gel; Kit - Topical, For suspension - Oral, Wafer - Oral, Capsule, delayed release pellets - Oral, Kit - Topical, Swab, Capsule, delayed release, Ointment - Ophthalmic, Solution, Powder, for suspension - Oral, Swab - Topical, Injection, powder, for solution - Intravenous, Gel; Kit, Powder, Capsule - Oral, Liquid, Capsule, delayed release - Oral, Tablet, delayed release, Liquid - Oral, Tablet, coated, Powder - Oral, Wafer, Ophthalmic, Capsule, delayed release pellets, Lotion; Swab, Powder, for solution, Lotion - Topical, Capsule, coated pellets, Lotion; Swab - Topical, Ointment - Topical, For suspension, Lotion, Capsule, Delayed Release
Lower Respiratory Tract Infection (LRTI)
, 5.0 mg/mL, 50.0 mg/mL, 0.005 mg/mg, 15.0 mg/mL, 20.0 mg/mL, 250.0 mg, 200.0 mg/mL, 500.0 mg, 100.0 mg/mL, 250.0 mg/mL, 200.0 mg, 25.0 mg/mL, 125.0 mg/mL, 40.0 mg/mL, 1000.0 mg, 400.0 mg/mL, 20.0 mg, 0.12 mg/mg, 600.0 mg, 0.03 mg/mg, 0.0012 mg/mg, 333.0 mg, 3.0 %, 400.0 mg, 0.0005 mg/mg, 0.008 mL/mL, 0.02 mg/mg, 0.5 %, 4.0 %, 2.0 %, 3.1 mg/mg
Granule, for suspension, Tablet, film coated - Oral, , Tablet, Tablet, delayed release - Oral, Injection, powder, lyophilized, for solution, Gel - Topical, Capsule, Oral, Capsule, coated pellets - Oral, Solution - Topical, Suspension, Intravenous, Capsule, Delayed Release - Oral, Suspension - Oral, Powder, for solution - Intravenous, Ointment, Gel, Injection, powder, for solution, Topical, Powder, for solution - Oral, Tablet, film coated, Tablet - Oral, Tablet, coated - Oral, Kit, Powder, for suspension, Granule, for suspension - Oral, Injection, powder, lyophilized, for solution - Intravenous, Gel; Kit - Topical, For suspension - Oral, Wafer - Oral, Capsule, delayed release pellets - Oral, Kit - Topical, Swab, Capsule, delayed release, Ointment - Ophthalmic, Solution, Powder, for suspension - Oral, Swab - Topical, Injection, powder, for solution - Intravenous, Gel; Kit, Powder, Capsule - Oral, Liquid, Capsule, delayed release - Oral, Tablet, delayed release, Liquid - Oral, Tablet, coated, Powder - Oral, Wafer, Ophthalmic, Capsule, delayed release pellets, Lotion; Swab, Powder, for solution, Lotion - Topical, Capsule, coated pellets, Lotion; Swab - Topical, Ointment - Topical, For suspension, Lotion, Capsule, Delayed Release
Warnings
Benzamycin has nine contraindications, so it should not be taken while experiencing the conditions delineated in the following table.Benzamycin ContraindicationsCondition
Risk Level
Notes
Toxoplasma Infections
Do Not Combine
Toxoplasma Infections
Do Not Combine
Toxoplasma Infections
Do Not Combine
Toxoplasma Infections
Do Not Combine
Toxoplasma Infections
Do Not Combine
Toxoplasma Infections
Do Not Combine
Toxoplasma Infections
Do Not Combine
Toxoplasma Infections
Do Not Combine
Severe Hypersensitivity Reactions
Do Not Combine
Erythromycin may interact with Toxoplasma Infections
Common Benzamycin Drug Interactions
Drug Name
Risk Level
Description
Alectinib
Major
The metabolism of Alectinib can be decreased when combined with Erythromycin.
Anagrelide
Major
The risk or severity of QTc prolongation can be increased when Erythromycin is combined with Anagrelide.
Arsenic trioxide
Major
The risk or severity of QTc prolongation can be increased when Erythromycin is combined with Arsenic trioxide.
Atorvastatin
Major
The serum concentration of Atorvastatin can be increased when it is combined with Erythromycin.
Bendamustine
Major
The serum concentration of Bendamustine can be increased when it is combined with Erythromycin.
Benzamycin Toxicity & Overdose RiskThe lowest toxic dose of erythromycin in rats has been found to be 9272mg/kg. Overdosing on erythromycin can lead to side effects such as diarrhea, nausea, stomach cramps, and vomiting. If an overdose occurs, the drug should be stopped immediately and attempts should be made to quickly remove unabsorbed drug from the system. Peritoneal dialysis or hemodialysis will not be effective in removing the drug.
Benzamycin Novel Uses: Which Conditions Have a Clinical Trial Featuring Benzamycin?
53 active investigations are currently assessing the potential of Benzamycin to treat Streptococcus pyogenes, treponema pallidum infection and Rheumatic Fever.Condition
Clinical Trials
Trial Phases
Streptococcus pyogenes
0 Actively Recruiting
Urinary Tract Infection (UTI)
24 Actively Recruiting
Phase 2, Phase 1, Phase 4, Phase 3, Not Applicable
Listeria monocytogenes infection
0 Actively Recruiting
Syphilis
6 Actively Recruiting
Phase 4, Not Applicable, Phase 3
Conjunctivitis
0 Actively Recruiting
Urethritis
0 Actively Recruiting
Gastroparesis
23 Actively Recruiting
Phase 3, Not Applicable, Phase 2, Early Phase 1
Respiratory Tract Infections
2 Actively Recruiting
Phase 3, Phase 2
Communicable Diseases
0 Actively Recruiting
pneumonia of infancy
0 Actively Recruiting
Sulfonamides
0 Actively Recruiting
Granuloma Inguinale
0 Actively Recruiting
Corynebacterium minutissimum infection
0 Actively Recruiting
Endophthalmitis
0 Actively Recruiting
penicillins
1 Actively Recruiting
Phase 4
Acne
7 Actively Recruiting
Phase 4, Early Phase 1, Not Applicable
Ureaplasma urealyticum
0 Actively Recruiting
Staphylococcal Skin Infections
1 Actively Recruiting
Phase 3
penicillins
0 Actively Recruiting
Lymphogranuloma Venereum
0 Actively Recruiting
Benzamycin Reviews: What are patients saying about Benzamycin?
5Patient Review
4/6/2008 I found that my skin dried out a bit when I first started using this product, but it improved after a few weeks.
5Patient Review
1/27/2013 I've used this medication for about five years now, and it's done wonders for my acne. I was getting big welts all over my face, as well as scarring, but this has helped to clear things up significantly. In addition to this medication, my dermatologist recommended using a day cream called retisola to help with dryness and a pill called minocycline to help with inflammation and prevent new breakouts.
5Patient Review
10/30/2017 This has been a life-saver for me, I've been using it consistently for over a year now and have no intention of stopping anytime soon!
4.7Patient Review
12/2/2007 The only issue I have with this product is that it dries my eyes out when used as directed. Otherwise, it's great!
3.7Patient Review
9/21/20072.7Patient Review
5/7/2010 I've been using this for a while now, and unfortunately I haven't seen much improvement. If anything, my skin has gotten worse. The only silver lining is that pimples seem to heal faster when on this medication, but more keep popping up.
Patient Q&A Section about benzamycin
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.What kind of patient would get Benzamycin?
"This medication is used to treat acne. It may be used alone or with other medications. It belongs to a class of drugs called topical acne agents. It is not known if this drug is safe and effective in children younger than 12 years of age."
Answered by AI
How long does it take Benzamycin to work?
"If you stop using this product, your acne may come back.
If you discontinue use of this product, your acne may worsen."
Answered by AI
Is Benzamycin good for acne?
"Benzamycin is a topical combination medication that works well to treat acne. It contains erythromycin and benzoyl peroxide, which work together to kill acne-causing bacteria and reduce inflammation."
Answered by AI
What is Benzamycin gel used for?
"Benzamycin is a combination of erythromycin, an antibiotic, and benzoyl peroxide, a medication with antibacterial and mild drying properties. It is used to treat acne."
Answered by AI